A Prospective Evaluation of Filler for Chin Enhancement
Brief description of study
This research study will evaluate changes in chin volume following treatment with an FDA-approved hyaluronic acid filler (Restylane Lyft) manufactured by Galderma that is used as part of standard care for chin augmentation. The primary goal of the study is to measure how chin volume changes over time after filler treatment using specialized 3D imaging technology (VECTRA imaging). A secondary goal is to compare these volumetric changes with data previously collected from patients treated with a different hyaluronic acid filler product (Juvderm).
Participants in the study will receive standard-of-care chin filler treatment and will undergo VECTRA 3D facial imaging before treatment, immediately after treatment, and at follow-up visits approximately 14, 30, and 90 days after injection. Participants will also complete FACE-Q questionnaires at the same time points to assess patient satisfaction and perception of treatment outcomes.
No additional invasive procedures beyond standard filler treatment will be performed as part of the study. The information collected may help improve understanding of how different filler products maintain volume over time and may help guide future cosmetic treatment decisions.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: 22 years - 55 years
-
Gender: All
TBD
Find a site
,
Send a message
Enter your contact details to connect with study team
Primary Contact
Interested in the study
Select a study center that’s convenient for you, and get in touch with the study team.
Contact a study centerPlease choose between Voice or SMS based delivery of verification code
or